In AML, KMT2A (also known as MLL) is a well-studied KMTs that primarily activates transcription of cell differentiation genes by catalyzing H3K4 trimethylation through its SET domain (Xia et al., 2003). Here, KMT2A is linked to acute myeloid leukemia.